Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-001840
Filing Date
2025-03-13
Accepted
2025-03-13 17:03:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5571
  Complete submission text file 0001950047-25-001840.txt   7116
Mailing Address 750 BATTERY ST STE 600 SAN FRANCISCO CA 94111
Business Address
CRAVES FRED B (Reporting) CIK: 0001014095 (see all company filings)

Type: 144

Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Subject) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-33277 | Film No.: 25736721
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)